DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $85,525,491 | +12.4% | 322,227 | +9.4% | 0.74% | -0.3% |
| Q3 2022 | $76,078,000 | +11038.8% | 294,545 | +10825.3% | 0.74% | +10471.4% |
| Q2 2022 | $683,000 | -20.5% | 2,696 | -7.9% | 0.01% | 0.0% |
| Q1 2022 | $859,000 | -11.3% | 2,927 | -0.5% | 0.01% | -12.5% |
| Q4 2021 | $968,000 | -22.9% | 2,942 | -28.6% | 0.01% | -20.0% |
| Q3 2021 | $1,255,000 | -80.0% | 4,121 | -82.4% | 0.01% | -82.5% |
| Q2 2021 | $6,270,000 | +504.6% | 23,364 | +407.0% | 0.06% | +470.0% |
| Q1 2021 | $1,037,000 | -0.2% | 4,608 | -1.5% | 0.01% | -9.1% |
| Q4 2020 | $1,039,000 | -1.0% | 4,679 | -4.0% | 0.01% | -15.4% |
| Q3 2020 | $1,050,000 | +18.1% | 4,874 | -3.0% | 0.01% | +8.3% |
| Q2 2020 | $889,000 | -99.8% | 5,027 | +30.3% | 0.01% | +33.3% |
| Q1 2020 | $533,847,000 | -9.8% | 3,857 | -0.0% | 0.01% | +12.5% |
| Q4 2019 | $592,126,000 | +5.4% | 3,858 | -0.8% | 0.01% | +14.3% |
| Q3 2019 | $561,688,000 | -6.4% | 3,889 | -7.4% | 0.01% | -12.5% |
| Q2 2019 | $600,121,000 | -2.2% | 4,199 | -9.7% | 0.01% | 0.0% |
| Q1 2019 | $613,761,000 | +25.9% | 4,649 | -1.7% | 0.01% | 0.0% |
| Q4 2018 | $487,448,000 | -4.8% | 4,727 | +0.3% | 0.01% | +14.3% |
| Q3 2018 | $512,115,000 | +0.6% | 4,713 | -8.7% | 0.01% | 0.0% |
| Q2 2018 | $509,287,000 | -7.4% | 5,161 | -8.1% | 0.01% | 0.0% |
| Q1 2018 | $550,058,000 | -26.2% | 5,618 | -30.1% | 0.01% | -30.0% |
| Q4 2017 | $745,809,000 | +8.2% | 8,035 | 0.0% | 0.01% | +11.1% |
| Q3 2017 | $689,242,000 | -0.5% | 8,035 | -2.1% | 0.01% | -10.0% |
| Q2 2017 | $692,420,000 | – | 8,205 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |